Cargando…

A new generation of pPRIG-based retroviral vectors

BACKGROUND: Retroviral vectors are valuable tools for gene transfer. Particularly convenient are IRES-containing retroviral vectors expressing both the protein of interest and a marker protein from a single bicistronic mRNA. This coupled expression increases the relevance of tracking and/or selectio...

Descripción completa

Detalles Bibliográficos
Autores principales: Albagli-Curiel, Olivier, Lécluse, Yann, Pognonec, Philippe, Boulukos, Kim E, Martin, Patrick
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2007
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2241607/
https://www.ncbi.nlm.nih.gov/pubmed/18053131
http://dx.doi.org/10.1186/1472-6750-7-85
_version_ 1782150519607787520
author Albagli-Curiel, Olivier
Lécluse, Yann
Pognonec, Philippe
Boulukos, Kim E
Martin, Patrick
author_facet Albagli-Curiel, Olivier
Lécluse, Yann
Pognonec, Philippe
Boulukos, Kim E
Martin, Patrick
author_sort Albagli-Curiel, Olivier
collection PubMed
description BACKGROUND: Retroviral vectors are valuable tools for gene transfer. Particularly convenient are IRES-containing retroviral vectors expressing both the protein of interest and a marker protein from a single bicistronic mRNA. This coupled expression increases the relevance of tracking and/or selection of transduced cells based on the detection of a marker protein. pAP2 is a retroviral vector containing eGFP downstream of a modified IRES element of EMCV origin, and a CMV enhancer-promoter instead of the U3 region of the 5'LTR, which increases its efficiency in transient transfection. However, pAP2 contains a limited multicloning site (MCS) and shows weak eGFP expression, which previously led us to engineer an improved version, termed pPRIG, harboring: i) the wild-type ECMV IRES sequence, thereby restoring its full activity; ii) an optimized MCS flanked by T7 and SP6 sequences; and iii) a HA tag encoding sequence 5' of the MCS (pPRIG HAa/b/c). RESULTS: The convenience of pPRIG makes it a good basic vector to generate additional derivatives for an extended range of use. Here we present several novel pPRIG-based vectors (collectively referred to as PRIGs) in which : i) the HA tag sequence was inserted in the three reading frames 3' of the MCS (3'HA PRIGs); ii) a functional domain (ER, VP16 or KRAB) was inserted either 5' or 3' of the MCS (« modular » PRIGs); iii) eGFP was replaced by either eCFP, eYFP, mCherry or puro-R (« single color/resistance » PRIGs); and iv) mCherry, eYFP or eGFP was inserted 5' of the MCS of the IRES-eGFP, IRES-eCFP or IRES-Puro-R containing PRIGs, respectively (« dual color/selection » PRIGs). Additionally, some of these PRIGs were also constructed in a pMigR MSCV background which has been widely used in pluripotent cells. CONCLUSION: These novel vectors allow for straightforward detection of any expressed protein (3'HA PRIGs), for functional studies of chimeric proteins (« modular » PRIGs), for multiple transductions and fluorescence analyses of transduced cells (« single color/resistance » PRIGs), or for quantitative detection of studied proteins in independently identified/selected transduced cells (« dual color/selection » PRIGs). They maintain the original advantages of pPRIG and provide suitable tools for either transient or stable expression and functional studies in a large range of experimental settings.
format Text
id pubmed-2241607
institution National Center for Biotechnology Information
language English
publishDate 2007
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-22416072008-02-13 A new generation of pPRIG-based retroviral vectors Albagli-Curiel, Olivier Lécluse, Yann Pognonec, Philippe Boulukos, Kim E Martin, Patrick BMC Biotechnol Methodology Article BACKGROUND: Retroviral vectors are valuable tools for gene transfer. Particularly convenient are IRES-containing retroviral vectors expressing both the protein of interest and a marker protein from a single bicistronic mRNA. This coupled expression increases the relevance of tracking and/or selection of transduced cells based on the detection of a marker protein. pAP2 is a retroviral vector containing eGFP downstream of a modified IRES element of EMCV origin, and a CMV enhancer-promoter instead of the U3 region of the 5'LTR, which increases its efficiency in transient transfection. However, pAP2 contains a limited multicloning site (MCS) and shows weak eGFP expression, which previously led us to engineer an improved version, termed pPRIG, harboring: i) the wild-type ECMV IRES sequence, thereby restoring its full activity; ii) an optimized MCS flanked by T7 and SP6 sequences; and iii) a HA tag encoding sequence 5' of the MCS (pPRIG HAa/b/c). RESULTS: The convenience of pPRIG makes it a good basic vector to generate additional derivatives for an extended range of use. Here we present several novel pPRIG-based vectors (collectively referred to as PRIGs) in which : i) the HA tag sequence was inserted in the three reading frames 3' of the MCS (3'HA PRIGs); ii) a functional domain (ER, VP16 or KRAB) was inserted either 5' or 3' of the MCS (« modular » PRIGs); iii) eGFP was replaced by either eCFP, eYFP, mCherry or puro-R (« single color/resistance » PRIGs); and iv) mCherry, eYFP or eGFP was inserted 5' of the MCS of the IRES-eGFP, IRES-eCFP or IRES-Puro-R containing PRIGs, respectively (« dual color/selection » PRIGs). Additionally, some of these PRIGs were also constructed in a pMigR MSCV background which has been widely used in pluripotent cells. CONCLUSION: These novel vectors allow for straightforward detection of any expressed protein (3'HA PRIGs), for functional studies of chimeric proteins (« modular » PRIGs), for multiple transductions and fluorescence analyses of transduced cells (« single color/resistance » PRIGs), or for quantitative detection of studied proteins in independently identified/selected transduced cells (« dual color/selection » PRIGs). They maintain the original advantages of pPRIG and provide suitable tools for either transient or stable expression and functional studies in a large range of experimental settings. BioMed Central 2007-11-30 /pmc/articles/PMC2241607/ /pubmed/18053131 http://dx.doi.org/10.1186/1472-6750-7-85 Text en Copyright © 2007 Albagli-Curiel et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Methodology Article
Albagli-Curiel, Olivier
Lécluse, Yann
Pognonec, Philippe
Boulukos, Kim E
Martin, Patrick
A new generation of pPRIG-based retroviral vectors
title A new generation of pPRIG-based retroviral vectors
title_full A new generation of pPRIG-based retroviral vectors
title_fullStr A new generation of pPRIG-based retroviral vectors
title_full_unstemmed A new generation of pPRIG-based retroviral vectors
title_short A new generation of pPRIG-based retroviral vectors
title_sort new generation of pprig-based retroviral vectors
topic Methodology Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2241607/
https://www.ncbi.nlm.nih.gov/pubmed/18053131
http://dx.doi.org/10.1186/1472-6750-7-85
work_keys_str_mv AT albaglicurielolivier anewgenerationofpprigbasedretroviralvectors
AT lecluseyann anewgenerationofpprigbasedretroviralvectors
AT pognonecphilippe anewgenerationofpprigbasedretroviralvectors
AT boulukoskime anewgenerationofpprigbasedretroviralvectors
AT martinpatrick anewgenerationofpprigbasedretroviralvectors
AT albaglicurielolivier newgenerationofpprigbasedretroviralvectors
AT lecluseyann newgenerationofpprigbasedretroviralvectors
AT pognonecphilippe newgenerationofpprigbasedretroviralvectors
AT boulukoskime newgenerationofpprigbasedretroviralvectors
AT martinpatrick newgenerationofpprigbasedretroviralvectors